ArticleFrontiers in immunology2023

The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study.

Yuxiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.